Immunomodulatory proteins of orthopoxviruses

Molekulyarnaya Biologiya

Volumn 37, Issue 1, 2003, Pages 41-53

  Shchelkunov, S N ^a  

^a N N BLOKHIN NATIONAL MEDICAL RESEARCH CENTER OF ONCOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON; VIRULENCE FACTOR; VIRUS PROTEIN;

COWPOX; GENE FUNCTION; GENE STRUCTURE; HUMAN; IMMUNE RESPONSE; IMMUNOMODULATION; INFLAMMATION; MONKEYPOX; NONHUMAN; ORTHOPOXVIRUS; REVIEW; SMALLPOX; VACCINIA VIRUS; VIRULENCE; VIRUS GENE; VIRUS INFECTION; AMINO ACID SEQUENCE; ANIMAL; DRUG ANTAGONISM; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR GENETICS; PATHOGENICITY; PHYSIOLOGY; POXVIRUS INFECTION; SEQUENCE HOMOLOGY; VIRUS GENOME;

VACCINIA VIRUS; VARIOLA;

AMINO ACID SEQUENCE; ANIMALS; GENOME, VIRAL; HUMANS; INTERFERONS; MOLECULAR SEQUENCE DATA; ORTHOPOXVIRUS; POXVIRIDAE INFECTIONS; SEQUENCE HOMOLOGY, AMINO ACID; VIRAL PROTEINS; VIRULENCE;

EID: 0037667695     PISSN: 00268984     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (73)

1. Alcami A., Koszinowski U.H. 2000. Viral mechanisms of immune evasion. Immunol. Today. 21, 447-455.
2. Moss B. 1996. Poxviridae: the viruses and their replication. In: Virology. Eds Fields B.N., Knipe D.M., Chanock R.M., Monath T.P., Howley P.M., Melnick J.L., Roizman B., Straus S.E. Philadelphia: Lippincott-Raven. 2, pp. 2637-2671.
3. Jezek Z., Fenner F. 1988. Human monkeypox. Monog. Virol. 17, 1-140.
4. Mukinda V.B.K., Mwema G., Kilundu M., Heymann D.L., Khan A.S., Esposito J.J. 1997. Re-emergence of human monkeupox in Zaire in 1996. Lancet. 349, 1448-1450.
5. Hutin Y.J.F., Williams R.J., Malfait P., Pebody R., Loparev V.N., Ropp S.L., Rodriguez M., Knight J.C., Tshioko F.K., Khan A.S., Szczeniowski M.V., Esposito J.J. 2001. Outbreak of human monkeypox, Democratic Republic of Congo, 1996-1997. Emerg. Infec. Dis. 7, 434-438.
6. Breman J.G. 2000. Monkeypox: an emerging infection for humans? In: Emerging Infectionst. 4, eds. Scheid W.M., Craig W.A., Hughes J.M., Washington D.C.: ASM Press, pp. 45-67.
7. Marennikova S.S., Shelukhina E.A., Efremova E.V. 1984. New outlook on the biology of cowpox virus. Acta Virol. 57, 437-444.
8. Marennikova S.S., Gashnikov P.V., Zhukova O.A., Ryabchikova E.I., Streltsov V.V., Ryazankina O.I., Chekunova E.V., Yanova N.N., Shchelkunov S.N. 1996. Biotype and genetic characterization of the isolate of cowpox virus having caused infection in a child. Zh. Microbiol. 4, 6-10.
9. Stolz W., Gotz A., Thomas P., Ruzicka T., Suss R., Landthaler M., Mahnel H., Czerny C-P. 1996. Characteristic but unfamiliar - the cowpox infection, transmitted by a domestic cat. Dermatology. 193, 140-143.
10. Czerny C.-P., Eis-Hubinger A.M., Mayr A., Schnewies K.E., Pfeiff B. 1991. Animal poxviruses transmitted from cat to man: current event with lethal end. Zentralhl. Veterinarmed. 38, 421-431.
11. Shchelkunov S.N., Blinov V.M., Sandakhchiev L.S. 1993. Genes of variola and vaccinia viruses necessary to overcome the host protective mechanisms. FEBS Lett. 319, 80-83.
12. Shchelkunov S.N., Blinov V.M., Sandakhchiev L.S. 1993. Ankyrin-like proteins of variola and vaccinia viruses. FEBS Lett. 319, 163-165.
13. Shchelkunov S.N., Resenchuk S.M., Totmenin A.V., Blinov V.M., Marennikova S.S., Sandakhchiev L.S. 1993. Comparison of the genetic maps of variola and vaccinia viruses. FEBS Lett. 327, 321-324.
14. Shchelkunov S.N., Massung R.F., Esposito J.J. 1995. Comparison of the genome DNA sequences of Bangladesh-1975 and India-1967 variola viruses. Virus Res. 36, 107-118.
15. Shchelkunov S.N., Totmenin A.V., Loparev V.N., Safronov P.P., Gutorov V.V., Chizhikov V.E., Knight J.C., Parsons J.M., Massung R.F., Esposito J.J. 2000. Alastrim smallpox variola minor virus genome DNA sequences. Virology. 266, 361-386.
16. Shchelkunov S.N., Totmenin A.V., Babkin I.V., Safronov P.P., Ryazankina O.J., Petrov N.A., Gutorov V.V., Uvarova E.A., Mikheev M.V., Sisler J.R., Esposito J.J., Jahrling P.B., Moss B., Sandakhchiev L.S. 2001. Human monkeypox and smallpox viruses: genomic comparison. FEBS Lett. 509, 66-70.
17. Shchelkunov S.N., Totmenin A.V., Safronov P.P., Mikheev M.V., Gutorov V.V., Ryazankina O.I., Petrov N.A., Babkin I.V., Uvarova E.A., Sandakhchiev L.S., Sisler J.R., Esposito J.J., Damon I.K., Jahrling P.B., Moss B. 2002. Analysis of the monkeypox virus genome. Virology. 297, 172-194.
18. Shchelkunov S.N., Safronov P.P., Totmenin A.V., Petrov N.A., Ryazankina O.I., Gutorov V.V., Kotwal G.J. 1998. The genomic sequence analysis of the left and fight species-specific terminal region of a cowpox virus strain reveals unique sequences and a cluster of intact ORFs for immunomodulatory and host range proteins. Virology. 243, 432-460.
19. Moss B., Shisler J.L. 2001. Immunology 101 at poxvirus U: immune evasion genes. Semin. Immunol. 13, 59-66.
20. Kotwal GJ. 1996. The great escape - immune evasion by pathogens. Immunologist. 4, 157-164.
21. Goebel S.J., Johnson O.P., Perkus M.E., Davis S.W., Winslow J.P., Paoletti E. 1990. The complete DNA sequence of vaccinia virus. Virology. 179, 247-266.
22. Tracey K.J., Cerami A. 1994. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Ann. Rev. Med. 45, 491-503.
23. Palumbo G.J., Pickup D.J., Frederickson T.N., McIntyre L.J., Buller R.M.L. 1989. Inhibition of an inflammatory response is mediated by 38-kDa protein of cowpox virus. Virology. 172, 262-273.
24. Palunbo G.L., Glasgow W.C., Buller R.M.L. 1993. Poxvirus-induced alteration of arachidonate metabolism. Proc. Natl. Acad Sci. USA. 90, 2020-2024.
25. Shchelkunov S.N. 2001. Species-specific differences in organization of molecular virulence factors of variola, cowpox, and vaccinia virus. Infec. Dis. Rev. Suppl. 3, 16-25.
26. Smith G.L., Chan Y.S. 1991. Two vaccinia virus proteins structurally related to the interleukin-1 receptor and the immunoglobulin superfamily. J. Gen. Virol. 72, 511-518.
27. Alcami A., Smith, G.L. 1992. A soluble receptor for interleukin-1 beta encoded by vaccinia virus: a novel mechanism of viral modulation of the host response to infection. Cell. 71, 153-167.
28. Alcami A., Smith G.L. 1996. A mechanism for the inhibition of fever by a virus. Proc. Natl. Acad. Sci. USA. 93, 11029-11034.
29. Shchelkunov S.N. 1995. Functional organization of variola major and vaccinia virus genomes. Virus Genes. 10, 53-71.
30. Upton C., Macen J.L., Schreiber M., McFadden G. 1991. Myxoma virus expresses secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology. 184, 370-382.
31. Smith C.A., Hu F.-Q., Smith T.D., Richards C.L., Smolak P., Goodwin R.G., Pickup D.J. 1996. Cowpox virus genome encodes a second soluble homologue of cellular TNF receptors, distinct from CrmB, that binds TNF but not Lt α. Virology. 223, 132-147.
32. Loparev V.N., Parsons J.M., Knight J.C., Panus J.F., Ray C.A., Buller R.M., Pickup D.J., Esposito J.J. 1998. A third distinct tumor necrosis factor receptor of orthopoxviruses. Proc. Natl. Acad. Sci. USA. 95, 3786-3791.
33. Saravia M., Alcami A. 2001. CrmE, a novel soluble tumor necrosis factor receptor encoded by poxviruses. J. Virol. 75, 226-233.
34. Seregin S.V., Babkina I.N., Nesterov A.E., Sinyakov A.N., Shchelkunov S.N. 1996. Comparative studies of gamma-interferon receptor-like proteins of variola major and variola minor viruses. FEBS Lett. 382,79-83.
35. Upton C., Mossman K., McFadden G. 1992. Encoding of a homolog of IFN-γ receptor by myxoma virus. Science. 258, 1369-1372.
36. Mossman K., Upton C., Buller R.M., McFadden G. 1995. Species specificity of ectromelia virus and vaccinia virus interferon-gamma binding proteins. Virology. 208, 762-769.
37. Mossman K., Nation P., Macen J., Garbutt M., Lucas A., McFadden G. 1996. Myxoma virus M-T7, a secreted homolog of the interferon-gamma receptor, is a critical virulence factor for the development of myxomatosis in European rabbis. Virology. 215, 17-30.
38. Alcami A., Smith G.L. 1995. Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity. J. Virol. 69, 4633-4639.
39. Rollins B.J. 1997. Chemokines. Blood. 90, 909-928.
40. Patel A.H., Gaffney D.F., Subak-Sharpe J.H., Stow N.D. 1990. DNA sequence of the gene encoding a major secreted protein of vaccinia virus, strain Lister. J. Gen. Virol. 71, 2013-2021.
41. Smith C.A., Smith T.D., Smolak P.J., Friend D., Hagen H., Gerhart M., Park L., Pickup D.J., Torrance D., Mohler K., Schooley K., Goodwin R.G. 1997. Poxvirus genomes encode a secreted, soluble protein that preferentially inhibits β chemokine activity yet lacks sequence homology to known chemokine receptors. Virology. 236, 316-327.
42. Kotwal G.J., Moss B. 1988. Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins. Nature. 335, 176-178.
43. Liszewski M.K., Atkinson J.P. 1998 in: The human complement system in health and disease. Eds Volanakis J.E., Frank M.M. New York-Basel-Hong Kong: Marcel Dekker, Inc., pp. 149-165.
44. Aso T., Okamura S., Matsuguchi T., Sakamoto N., Sata T., Niho Y. 1991. Genomic organization of the alpha chain of the human C4b-binding protein gene. Biochem. Biophys. Res. Commun. 174, 222-227.
45. Kirkitadze M.D., Henderson C, Price N.C., Kelly S.M., Mullin N.P., Parkinson J., Dryden D.T.F., Barlow P.N. 1999. Central modules of the vaccinia virus complement control protein are not in extensive contact. Biochem. J. 344, 167-175.
46. Smith S.A., Mullin N.P., Parkinson J., Shchelkunov S.N., Totmenin A. V., Loparev V.N., Srisatjaluk R., Reynolds D.N., Keeling K.L., Justus D.E., Barlow P.N., Kotwal G.J. 2000. Conserved surface-exposed K/R-X-K/R motifs and net positive charge on poxvirus complement control proteins serve as putative heparin binding sites and contribute to inhibition of molecular interactions with human endothelial cells: a novel mechanism for evasion of host defense. J. Virol. 74, 5659-5666.
47. Isaacs S.N., Kotwal G.J., Moss B. 1992. Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc. Natl. Acad. Sci. USA. 89, 628-632.
48. Miller G.G., Shchelkunov S.N., Kotwal G.J. 1997. The cowpox virus-encoded homolog of the vaccinia virus complement control protein is an inflammation modulatory protein. Virology. 229, 126-133.
49. Howard J., Justus D.E., Totmenin A.V., Shchelkunov S.N., Kotwal G.J. 1998. Molecular mimicry of the inflamation modulatory proteins (IMPs) of poxviruses: evasion of the inflammatory responce to preserve viral habitat. J. Leukoc. Biol. 64, 68-71.
50. Uvarova E.A., Shchelkunov S.N. 2001. Species-specific differences in the structure of orthopoxvirus complement-binding protein. Virus Res. 81, 39-45.
51. Rosengard A.M., Liu Y., Nie Z., Jimenez R. 2002. Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement. Proc. Natl. Acad. Sci. USA. 99, 8808-8813.
52. Comeau M.R., Johnson R., DuBose R.F., Petersen M., Gearing P., VandenBos T., Park L., Farrah T., Buller R.M., Cohen J.I., Strockbine L.D., Rauch C., Spriggs M.K. 1998. A poxvirus-encoded semaphorin induces cytokine production from monocytes and binds to a novel cellular semaphorin receptor, VESPR. Immunity. 8, 473-482.
53. Spriggs M.K. 1999. Shared resources between the neural and immune systems: semaphorins join the ranks. Curr. Oppin. Immunol. 11, 387-391.
54. Samuel C.E. 1991. Antiviral action of interferon. Interferon regulated cellular proteins and their surprisingly selective antiviral activities. Virology. 183, 1-11.
55. Varich N.L., Sychova I.V., Kaverin N.V., Antonova T.P., Chernos V.T. 1979. Transcription of both DNA strands of vaccinia virus genome in vivo. Virology. 96, 412-430.
56. Whitaker-Dowling P., Younger J.S. 1984. Characterization of a specific kinase inhibitory factor produced by vaccinia virus which inhibits the interferon-induced protein kinase. Virology. 137, 171-181.
57. Watson J.C., Chang H.-W., Jacobs B. 1991. Characterization of a vaccinia virus-encoded double-stranded RNA-binding protein that may be involved in inhibition of the double-stranded RNA-dependent protein kinase. Virology. 185, 206-216.
58. Davies M.V., Chang H.-W., Jacobs B.L., Kaufman R.J. 1993. The E3L and K3L vaccinia virus gene products stimulate translation through inhibition of the double-sranded RNA-dependent protein kinase by different mechanisms. J. Virol. 67, 1688-1692.
59. Beattie E., Tartaglia J., Paoletti E. 1991. Vaccinia-virus encoded eIF-2α homolog abrogates the antiviral effect of interferon. Virology. 183, 419-422.
60. Yuwen H., Cox J.H., Yewdell J.W., Bennink J.R., Moss B. 1993. Nuclear localization of a double-stranded RNA-binding protein encoded by the vaccinia virus E3L gene. Virology. 195, 732-744.
61. Romano P.R., Zhang F., Tan S.L., Garcia-Barrio M.T., Katze M.G., Dever T.E., Hinnebusch A.G. 1998. Inhibition of double-stranded RNA-dependent protein kinase PKR by vaccinia virus E3: role of complex formation and the E3 N-terminal domain. Mol. Cell. Biol. 18, 7304-7316.
62. Brandt T.A., Jacobs B.L. 2001. Both carboxy- and amino-terminal domains of the vaccinia virus interferon resistance gene, E3L, are required for pathogenesis in a mouse model. J. Virol. 75, 850-856.
63. Chang H.-W., Watson J.C., Jacobs B.L. 1992. The E3L gene of vaccinia virus encodes an inhibitor of the interferon-induced, double-stranded RNA-dependent protein kinase. Proc. Natl. Acad. Sci. USA. 89, 4825-4829.
64. Rivas C., Gil J., Melkova Z., Esteban M., Diaz-Guerra M. 1998. Vaccinia virus E3L protein is an inhibitor of the interferon (IFN)-induced 2-5A synthetase enzyme. Virology. 243, 406-414.
65. Symons J.A., Alcami A., Smith G.L. 1995. Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity. Cell. 81, 551-560.
66. Spriggs M.K. 1996. One step ahead of the game: Viral immunomodulatory molecules. Annu. Rev. Immunol. 14, 101-130.
67. Buller R.M.L., Palumbo G.J. 1991. Poxvirus pathogenesis. Microbiol. Rev. 55, 80-122.
68. + cytotoxic T lymphocytes in humans. J. Virol. 67, 1538-1544.
69. Okamura H., Tsutsui H., Kashiwamura S., Yoshimoto T., Nakanishi K. 1998. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 70, 281-289.
70. Novick D., Kim S.-H., Fantuzzi G., Reznikov L.L., Dinarello C.A., Rubinstein M. 1999. Interleukin-18 binding protein: a novel modulator of the ThI cytokine response. Immunity. 10, 127-136.
71. Born T.L., Morrison L.A., Esteban D.J., VandenBos T., Thebeau L.G., Chen N., Spriggs M.K., Sims J.E., Buller R.M.L. 2000. A poxvirus protein that binds to and inactivates IL-18, and inhibits NK cell response. J. Immunol. 164, 3246-3254.
72. Moore J.B., Smith G.L. 1992. Steroid hormone synthesis by a vaccinia enzyme: a new type of virus virulence factor. EMBO J. 11, 1973-1980.